Product
FTC/TAF
2 clinical trials
2 indications
Indication
Preexposure Prophylaxis for HIVIndication
HIV InfectionsClinical trial
A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Oral Islatravir Once-Monthly as Preexposure Prophylaxis in Cisgender Men and Transgender Women Who Have Sex With Men, and Are at High Risk for HIV-1 InfectionStatus: Completed, Estimated PCD: 2023-08-04
Clinical trial
A Phase IIb, Randomized, Partially Blind, Active Controlled, Dose-range Finding Study of GSK3640254 Compared to a Reference Arm of Dolutegravir, Each in Combination With Nucleoside Reverse Transcriptase Inhibitors, in HIV-1 Infected Antiretroviral Treatment-naive AdultsStatus: Terminated, Estimated PCD: 2022-09-05